| __timestamp | Perrigo Company plc | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 152500000 | 47795223 |
| Thursday, January 1, 2015 | 187800000 | 50426000 |
| Friday, January 1, 2016 | 184000000 | 70853000 |
| Sunday, January 1, 2017 | 167700000 | 78168000 |
| Monday, January 1, 2018 | 218600000 | 123757000 |
| Tuesday, January 1, 2019 | 187400000 | 140963000 |
| Wednesday, January 1, 2020 | 177700000 | 131773000 |
| Friday, January 1, 2021 | 122000000 | 210328000 |
| Saturday, January 1, 2022 | 123100000 | 235780000 |
| Sunday, January 1, 2023 | 122500000 | 244990000 |
Cracking the code
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Perrigo Company plc and Travere Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Perrigo's R&D expenses have shown a steady decline, dropping by approximately 20% from their peak in 2018. This trend suggests a strategic shift, possibly towards cost optimization or a focus on other business areas. In contrast, Travere Therapeutics has aggressively increased its R&D spending, with a remarkable 413% surge over the same period. By 2023, Travere's R&D expenses were nearly double those of Perrigo, highlighting its strategic focus on innovation and development.
These divergent paths underscore the varied approaches companies take in navigating the ever-evolving pharmaceutical industry.
Comparing Innovation Spending: Johnson & Johnson and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Perrigo Company plc
Comparing Innovation Spending: GSK plc and Perrigo Company plc
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Perrigo Company plc
Comparing Innovation Spending: Neurocrine Biosciences, Inc. and Perrigo Company plc
Analyzing R&D Budgets: Exelixis, Inc. vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Jazz Pharmaceuticals plc and Perrigo Company plc
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Perrigo Company plc vs Celldex Therapeutics, Inc.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Travere Therapeutics, Inc.
Analyzing R&D Budgets: MorphoSys AG vs Travere Therapeutics, Inc.
MannKind Corporation or Travere Therapeutics, Inc.: Who Invests More in Innovation?